Advancing the Science of Radiopharmaceuticals
Science of Radiopharmaceuticals
Your Partner -
Proposal to Product
IsoTherapeutics Group, LLC (IsoTherapeutics) is a radiopharmaceutical company that was founded in 2005 by two entrepreneur scientists with a passion for advancing the technology of radiopharmaceuticals. The company scientists, while employed at the Dow Chemical Company, developed QUADRAMET® a radiopharmaceutical for treatment of bone pain due to metastatic cancer, treatments for arthritis, osteoporosis, and osteomyelitis, just to name a few. IsoTherapeutics scientists have received over 100 patents for developing chemistry and radiopharmaceutical formulations.
IsoTherapeutics offers host of services to the pharmaceutical and life-science industries.
The range of services include helping customers/partners with early stage research from proof of concept for a new chemistry or drug molecule through making of the drug in a cGMP facility for preclinical studies. These services include:
IsoTherapeutics Group is located about 45 miles south of Houston at 1004 South Velasco Street in Angleton, Texas. The facility consists of three buildings equipped with offices, R&D laboratories, cGMP production area, documentation room, shipping and receiving, controlled storage areas and an animal research laboratory.